Table 1.
Descriptive measures for each group and pooled data, expressed as the mean (SD) for age, height, mass, and BMI and as the mean (95% CI) for FRAX data, T-scores, and L3 area.
| Descriptive measure | Group | Pooled | ||
|---|---|---|---|---|
| Primary osteoporosis | GIO | Control | ||
| N (% female) | 43 (95.3) | 13 (30.8) | 48 (83.3) | 104 (81.7) |
| Age (years) | 61.1 (5.0) | 63.7 (7.8) | 61.5 (5.6) | 62.1 (6.1) |
| Height (cm) | 163.1 (7.6) | 169.1 (8.7) | 166.8 (6.5) | 166.3 (7.6) |
| Mass (kg) | 61.8 (10.0)b,c | 75.6 (16.1)a | 71.9 (8.8) | 69.8 (11.6) |
| BMI (kg/m2) | 23.2 (3.0)b,c | 26.2 (3.7)a | 25.8 (2.8) | 25.1 (3.2) |
| FRAX major osteoporotic (%) | 4.5 (3.7 to 5.4)c | 6.0 (3.3 to 8.7)c | 2.6 (2.0 to 3.2) | 4.4 (3.0 to 5.8) |
| FRAX hip (%) | 1.1 (0.8 to 1.4) | 2.1 (0.8 to 3.4)c | 0.4 (0.1 to 0.7) | 1.2 (0.6 to 1.8) |
| T-score PA spine (L1–4) | −2.6 (−2.9 to −2.4)b,c | −1.6 (−2.4 to −0.9)a,c | 0.0 (−0.2 to 0.3) | −1.4 (−1.8 to −1.0) |
| T-score total hip | −2.0 (−2.2 to −1.8)b,c | −1.3 (−1.9 to −0.8)a,c | −0.2 (−0.4 to 0.1) | −1.8 (−1.5 to −0.8) |
| L3 area (ROI 1) (cm2) | 8.8 (8.1 to 9.5)b | 11.1 (10.1 to 12.0)a | 9.9 (9.1 to 10.0) | 9.9 (9.1 to 10.5) |
aSignificant difference compared to the primary osteoporosis group (P < 0.01); bsignificant difference compared to the GIO group (P < 0.01); csignificant difference compared to control group (P < 0.01).